EEC peptides have shown evidence of anti-inflammatory properties, with studies in animal models of IBD indicating that glucagon-like peptide 2 (GLP-2), from L cells, can have a protective role in disease progression [68]. The gene discussed is GCG; the disease is inflammatory bowel disease.